Cargando…

Robotic Liver Resection Versus Percutaneous Ablation for Early HCC: Short- and Long-Term Results

SIMPLE SUMMARY: Patients newly diagnosed with a single hepatocellular carcinoma (HCC) smaller than 3 cm that underwent robotic liver resection (RLR) benefit from a significantly higher potential of cure and tumor-related free survival compared to those that underwent percutaneous ablation (PA), with...

Descripción completa

Detalles Bibliográficos
Autores principales: Magistri, Paolo, Catellani, Barbara, Frassoni, Samuele, Guidetti, Cristiano, Olivieri, Tiziana, Assirati, Giacomo, Caporali, Cristian, Pecchi, Annarita, Serra, Valentina, Ballarin, Roberto, Guerrini, Gian Piero, Bagnardi, Vincenzo, Di Sandro, Stefano, Di Benedetto, Fabrizio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7761404/
https://www.ncbi.nlm.nih.gov/pubmed/33266096
http://dx.doi.org/10.3390/cancers12123578
_version_ 1783627560998928384
author Magistri, Paolo
Catellani, Barbara
Frassoni, Samuele
Guidetti, Cristiano
Olivieri, Tiziana
Assirati, Giacomo
Caporali, Cristian
Pecchi, Annarita
Serra, Valentina
Ballarin, Roberto
Guerrini, Gian Piero
Bagnardi, Vincenzo
Di Sandro, Stefano
Di Benedetto, Fabrizio
author_facet Magistri, Paolo
Catellani, Barbara
Frassoni, Samuele
Guidetti, Cristiano
Olivieri, Tiziana
Assirati, Giacomo
Caporali, Cristian
Pecchi, Annarita
Serra, Valentina
Ballarin, Roberto
Guerrini, Gian Piero
Bagnardi, Vincenzo
Di Sandro, Stefano
Di Benedetto, Fabrizio
author_sort Magistri, Paolo
collection PubMed
description SIMPLE SUMMARY: Patients newly diagnosed with a single hepatocellular carcinoma (HCC) smaller than 3 cm that underwent robotic liver resection (RLR) benefit from a significantly higher potential of cure and tumor-related free survival compared to those that underwent percutaneous ablation (PA), with comparable incidence of morbidity. Notably, the 20.8% incidence of satellitosis in the RLR group confirms that PA patients are at higher risk to obtain a not-radical treatment and, therefore, are more likely to need repeated treatments, which actually doubles the risk of morbidity in the long term. Therefore, therapeutic algorithms as well as down-staging protocols for HCC can be implemented with robotic approaches in high volume centers with extensive experience in the field of hepato-biliary surgery and minimally invasive approaches, to offer more opportunities to those patients. ABSTRACT: Background: The correct approach for early hepatocellular carcinoma (HCC) is debatable, since multiple options are currently available. Percutaneous ablation (PA) is associated in some series to reduced morbidity compared to liver resection (LR); therefore, minimally invasive surgery may play a significant role in this setting. Methods: All consecutive patients treated by robotic liver resection (RLR) or PA between January 2014 and October 2019 for a newly diagnosed single HCC, less than 3 cm in size (very early/early stages according to the Barcelona Clinic Liver Cancer (BCLC)) on chronic liver disease or liver cirrhosis, were enrolled in this retrospective study. The aim of this study was to compare short- and long-term outcomes to define the best approach in this specific cohort. Results: 60 patients fulfilled the inclusion criteria: 24 RLR and 36 PA. The two populations were homogeneous in terms of baseline characteristics. There were no statistically significant differences regarding the incidence of postoperative morbidity (RLR 38% vs. PA 19%, p = 0.15). The cumulative incidence of recurrence (CIR) was significantly higher in patients who underwent PA, with the one, two, and three years of CIR being 42%, 69%, and 73% in the PA group and 17%, 27%, and 27% in the RLR group, respectively. Conclusions: RLR provides a significantly higher potential of cure and tumor-related free survival in cases of newly diagnosed single HCCs smaller than 3 cm. Therefore, it can be considered as a first-line approach for the treatment of patients with those characteristics in high-volume centers with extensive experience in the field of hepatobiliary surgery and minimally invasive approaches.
format Online
Article
Text
id pubmed-7761404
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-77614042020-12-26 Robotic Liver Resection Versus Percutaneous Ablation for Early HCC: Short- and Long-Term Results Magistri, Paolo Catellani, Barbara Frassoni, Samuele Guidetti, Cristiano Olivieri, Tiziana Assirati, Giacomo Caporali, Cristian Pecchi, Annarita Serra, Valentina Ballarin, Roberto Guerrini, Gian Piero Bagnardi, Vincenzo Di Sandro, Stefano Di Benedetto, Fabrizio Cancers (Basel) Article SIMPLE SUMMARY: Patients newly diagnosed with a single hepatocellular carcinoma (HCC) smaller than 3 cm that underwent robotic liver resection (RLR) benefit from a significantly higher potential of cure and tumor-related free survival compared to those that underwent percutaneous ablation (PA), with comparable incidence of morbidity. Notably, the 20.8% incidence of satellitosis in the RLR group confirms that PA patients are at higher risk to obtain a not-radical treatment and, therefore, are more likely to need repeated treatments, which actually doubles the risk of morbidity in the long term. Therefore, therapeutic algorithms as well as down-staging protocols for HCC can be implemented with robotic approaches in high volume centers with extensive experience in the field of hepato-biliary surgery and minimally invasive approaches, to offer more opportunities to those patients. ABSTRACT: Background: The correct approach for early hepatocellular carcinoma (HCC) is debatable, since multiple options are currently available. Percutaneous ablation (PA) is associated in some series to reduced morbidity compared to liver resection (LR); therefore, minimally invasive surgery may play a significant role in this setting. Methods: All consecutive patients treated by robotic liver resection (RLR) or PA between January 2014 and October 2019 for a newly diagnosed single HCC, less than 3 cm in size (very early/early stages according to the Barcelona Clinic Liver Cancer (BCLC)) on chronic liver disease or liver cirrhosis, were enrolled in this retrospective study. The aim of this study was to compare short- and long-term outcomes to define the best approach in this specific cohort. Results: 60 patients fulfilled the inclusion criteria: 24 RLR and 36 PA. The two populations were homogeneous in terms of baseline characteristics. There were no statistically significant differences regarding the incidence of postoperative morbidity (RLR 38% vs. PA 19%, p = 0.15). The cumulative incidence of recurrence (CIR) was significantly higher in patients who underwent PA, with the one, two, and three years of CIR being 42%, 69%, and 73% in the PA group and 17%, 27%, and 27% in the RLR group, respectively. Conclusions: RLR provides a significantly higher potential of cure and tumor-related free survival in cases of newly diagnosed single HCCs smaller than 3 cm. Therefore, it can be considered as a first-line approach for the treatment of patients with those characteristics in high-volume centers with extensive experience in the field of hepatobiliary surgery and minimally invasive approaches. MDPI 2020-11-30 /pmc/articles/PMC7761404/ /pubmed/33266096 http://dx.doi.org/10.3390/cancers12123578 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Magistri, Paolo
Catellani, Barbara
Frassoni, Samuele
Guidetti, Cristiano
Olivieri, Tiziana
Assirati, Giacomo
Caporali, Cristian
Pecchi, Annarita
Serra, Valentina
Ballarin, Roberto
Guerrini, Gian Piero
Bagnardi, Vincenzo
Di Sandro, Stefano
Di Benedetto, Fabrizio
Robotic Liver Resection Versus Percutaneous Ablation for Early HCC: Short- and Long-Term Results
title Robotic Liver Resection Versus Percutaneous Ablation for Early HCC: Short- and Long-Term Results
title_full Robotic Liver Resection Versus Percutaneous Ablation for Early HCC: Short- and Long-Term Results
title_fullStr Robotic Liver Resection Versus Percutaneous Ablation for Early HCC: Short- and Long-Term Results
title_full_unstemmed Robotic Liver Resection Versus Percutaneous Ablation for Early HCC: Short- and Long-Term Results
title_short Robotic Liver Resection Versus Percutaneous Ablation for Early HCC: Short- and Long-Term Results
title_sort robotic liver resection versus percutaneous ablation for early hcc: short- and long-term results
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7761404/
https://www.ncbi.nlm.nih.gov/pubmed/33266096
http://dx.doi.org/10.3390/cancers12123578
work_keys_str_mv AT magistripaolo roboticliverresectionversuspercutaneousablationforearlyhccshortandlongtermresults
AT catellanibarbara roboticliverresectionversuspercutaneousablationforearlyhccshortandlongtermresults
AT frassonisamuele roboticliverresectionversuspercutaneousablationforearlyhccshortandlongtermresults
AT guidetticristiano roboticliverresectionversuspercutaneousablationforearlyhccshortandlongtermresults
AT olivieritiziana roboticliverresectionversuspercutaneousablationforearlyhccshortandlongtermresults
AT assiratigiacomo roboticliverresectionversuspercutaneousablationforearlyhccshortandlongtermresults
AT caporalicristian roboticliverresectionversuspercutaneousablationforearlyhccshortandlongtermresults
AT pecchiannarita roboticliverresectionversuspercutaneousablationforearlyhccshortandlongtermresults
AT serravalentina roboticliverresectionversuspercutaneousablationforearlyhccshortandlongtermresults
AT ballarinroberto roboticliverresectionversuspercutaneousablationforearlyhccshortandlongtermresults
AT guerrinigianpiero roboticliverresectionversuspercutaneousablationforearlyhccshortandlongtermresults
AT bagnardivincenzo roboticliverresectionversuspercutaneousablationforearlyhccshortandlongtermresults
AT disandrostefano roboticliverresectionversuspercutaneousablationforearlyhccshortandlongtermresults
AT dibenedettofabrizio roboticliverresectionversuspercutaneousablationforearlyhccshortandlongtermresults